Global life expectancy to rise by nearly 5 years by 2050, GBD 2021 study predicts

FHS
May 17, 2024
3:21 am

The latest findings from the Global Burden of Disease Study (GBD) 2021, published today in The Lancet, forecast that global life expectancy will increase by 4.9 years in males and 4.2 years in females between 2022 and 2050.

CYTIVA FDA IASO Bio IND for equecabtagene autoleucel

The IND clearance is for the autoimmune disease indications non-renal systemic lupus erythematosus and lupus nephritis. Credit: Sebastian Kaulitzki/Shutterstock. IASO Biotherapeutics has secured US Food

August 12, 2024

Updated: Oculis closes Phase 3 eye drop trial due to ‘administrative error’ from third party

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 28, 2024

Antibiotic overuse linked to poor record-keeping in healthcare settings

A lack of detailed record-keeping in clinics and emergency departments may be getting in the way of reducing the inappropriate use of antibiotics, a pair

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.